ACM
OGN icon

AlphaCrest Capital Management’s Organon & Co OGN Stock Holding History

AlphaCrest Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-81,835
Closed -$1.92M – 789
2022
Q3 		$1.92M Buy
+81,835
New +$2.47M 0.12% 249

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AlphaCrest Capital Management's OGN Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 81,835 shares — an estimated $1.92M sold.

AlphaCrest Capital Management first reported a position in OGN in Q3 2022 and held it in 1 quarter. The position peaked at $1.92M in Q3 2022. 823 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 81,835 Organon & Co shares in Q4 2022, an estimated $1.92M.
  • AlphaCrest Capital Management first reported a position in Organon & Co in Q3 2022 and held it in 1 quarter.
  • AlphaCrest Capital Management's Organon & Co position peaked at $1.92M in Q3 2022.
  • 823 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.